Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:WD
NYSE:WDDiversified Financial

Walker And Dunlop Expands European Role With ESG Zuiderpoort Refinancing

Walker & Dunlop (NYSE:WD) arranged a major ESG-focused refinancing for the Zuiderpoort office complex in Ghent, Belgium. The financing supports plans to upgrade the property, including a fossil fuel free HVAC system and other sustainability measures. The deal highlights the company’s role in cross border real estate financing and activity in Europe’s green property market. For you as an investor following Walker & Dunlop, this deal sits within the company’s core business of real estate...
NasdaqGS:ULCC
NasdaqGS:ULCCAirlines

A Look At Frontier Group Holdings (ULCC) Valuation After Full Year Loss And Softer Revenue Results

Why Frontier Group Holdings is back on investors’ radar Frontier Group Holdings (ULCC) has drawn fresh attention after reporting fourth quarter and full year 2025 results that paired softer revenue with a full year net loss and modest shifts in passenger metrics. The airline posted quarterly revenue of US$997 million versus US$1,002 million a year earlier, with net income of US$53 million compared with US$54 million. For 2025 as a whole, revenue was US$3.724b, while the company moved from net...
NasdaqGS:CVLT
NasdaqGS:CVLTSoftware

Is Slower SaaS ARR Growth and New Legal Scrutiny Altering The Investment Case For Commvault Systems (CVLT)?

In late January 2026, Commvault Systems reported that its SaaS annual recurring revenue growth had slowed to 40%, prompting multiple law firms, including Kessler Topaz Meltzer & Check and The Schall Law Firm, to open investigations into potential securities law violations. The combination of moderating SaaS momentum and legal scrutiny raises fresh questions about Commvault’s prior growth messaging and the resilience of its subscription transition. We’ll now examine how the SaaS growth...
NasdaqGS:ETOR
NasdaqGS:ETORCapital Markets

EToro Group (ETOR) Margin Stability With 1.6% Net Margin Tests Bullish Earnings Narratives

Latest FY 2025 Results Set the Stage for eToro Group (ETOR) eToro Group (ETOR) has put fresh numbers on the board for FY 2025, with fourth quarter revenue of about US$3.9b and basic EPS of US$0.79, alongside full year trailing twelve month EPS of US$2.58 on revenue of roughly US$13.8b. The company has seen quarterly revenue move from US$5.8b in Q4 2024 to US$3.9b in Q4 2025, while basic EPS shifted from US$0.78 to US$0.79 over the same period. Trailing twelve month revenue has ranged between...
NYSE:KFY
NYSE:KFYProfessional Services

Can Korn Ferry’s (KFY) Capital Efficiency Offset Flat Sales and Rising Costs?

In recent days, Korn Ferry has drawn fresh attention as analysts highlighted its high return on invested capital, solid balance sheet, and strong profit quality, even as it continues to contend with flat sales and higher expenses as a share of revenue. This contrast between financial strength and end-market challenges suggests investors are reconsidering how much Korn Ferry’s capital efficiency and flexibility can offset slower top-line momentum. We’ll now examine how this renewed focus on...
NasdaqGS:CTAS
NasdaqGS:CTASCommercial Services

A Look At Cintas (CTAS) Valuation After Fresh Analyst Coverage And Confidence In Its Quality Profile

Why fresh analyst coverage has put Cintas (CTAS) back on investors’ radar A recent coverage reinstatement by a major bank, coupled with public commentary on Cintas’s financial health, margins, and operations, has refocused attention on the stock as a quality candidate. See our latest analysis for Cintas. Recent interest from institutional investors and fresh analyst commentary have come against a backdrop where the latest 90 day share price return of 6.21% and 3 year total shareholder return...
SEHK:3898
SEHK:3898Machinery

A Look At Zhuzhou CRRC Times Electric’s Valuation After Buyback Launch And Strong 2025 Results

What the new buyback and earnings mean for shareholders Zhuzhou CRRC Times Electric (SEHK:3898) has put two major developments on the table for investors to weigh: a fresh share repurchase program covering up to 3.6% of its issued share capital and recently released full year 2025 results. See our latest analysis for Zhuzhou CRRC Times Electric. The recent buyback launch and full year 2025 results sit alongside a 30 day share price return of 9.06% and year to date share price return of...
SEHK:1
SEHK:1Industrials

A Look At CK Hutchison Holdings (SEHK:1) Valuation After Recent Share Price Momentum

Why CK Hutchison Holdings Is On Investors’ Radar CK Hutchison Holdings (SEHK:1) has drawn fresh attention after a strong past year in the market, with its share price showing gains over the past month, past 3 months, and year to date. See our latest analysis for CK Hutchison Holdings. The recent 19.3% 3 month share price return and 17.8% year to date share price return, alongside a 68.9% 1 year total shareholder return, suggest momentum has been building as investors reassess growth prospects...
NYSE:SXC
NYSE:SXCMetals and Mining

SunCoke Energy (SXC) Swings To Q4 EPS Loss And Tests Long Term Bullish Narratives

SunCoke Energy (SXC) closed FY 2025 with Q4 revenue of US$480.2 million and a basic EPS loss of US$1, while trailing twelve month figures show revenue of about US$1.8 billion and a basic EPS loss of roughly US$0.52. Over the past few quarters, revenue has moved between US$434.1 million and US$490.1 million, with quarterly basic EPS ranging from a small profit of roughly US$0.02 to US$0.36 before flipping to losses in the latest period. This pattern puts the focus squarely on how efficiently...
ASX:BTR
ASX:BTRMetals and Mining

How A Fixed-Price EPC Deal At Brightstar Resources (ASX:BTR) Has Changed Its Investment Story

Brightstar Resources has entered a fixed-price engineering, procurement and construction partnership with GR Engineering Services to advance its Goldfields Project in Western Australia, targeting construction from April 2026 and first gold production by June 2027 as part of its plan to build a multi-asset gold portfolio. This fixed-price EPC structure is important because it offers cost and schedule certainty, potentially reducing project execution risk for Brightstar’s expansion...
NYSE:RNG
NYSE:RNGSoftware

RingCentral Draws Attention As AI Jitters Meet Valuation Questions

Sector wide selling in software linked to anxiety about artificial intelligence has brought fresh attention to RingCentral, NYSE:RNG, and its business model. Investors are questioning how emerging AI tools could affect communications platforms like RingCentral and whether current pricing and demand trends are at risk. The pullback across software names has coincided with heightened debate over which companies are most exposed to disruption from AI led offerings. RingCentral’s share price...
NYSE:ALLE
NYSE:ALLEBuilding

Allegion (ALLE) Earnings Growth And 15.8% Margin Reinforce Steady Profit Narrative

Allegion FY 2025 Earnings Snapshot Allegion (ALLE) has wrapped up FY 2025 with fourth quarter revenue of US$1.03b and basic EPS of US$1.71, while trailing twelve month figures sit at US$4.07b in revenue and EPS of US$7.48, giving investors a clear view of the latest run rate. Over the past few quarters the company has seen revenue move from US$945.6m in Q4 2024 to above US$1b in several 2025 quarters. Quarterly EPS has ranged between roughly US$1.66 and US$2.19 over this period, supported by...
NYSE:H
NYSE:HHospitality

Hyatt Confronts Reputational Risk As Pritzker Exits And CEO Becomes Chair

Hyatt Hotels (NYSE:H) announced the immediate retirement of executive chairman Thomas J. Pritzker and his resignation from the board. Pritzker cited regret over his past association with Jeffrey Epstein and concerns about the impact on Hyatt's reputation. The board moved quickly to appoint CEO Mark S. Hoplamazian as chairman, consolidating leadership roles. Hyatt Hotels, known for its global portfolio of hotel and resort brands, now faces an important leadership reset at the board level...
XTRA:SRT3
XTRA:SRT3Life Sciences

Sartorius (XTRA:SRT3) Net Margin Recovery Tests Bullish Growth Narrative

Sartorius (XTRA:SRT3) FY 2025 earnings snapshot Sartorius (XTRA:SRT3) has wrapped up FY 2025 with fourth quarter revenue of €927.6 million and net income of €30.2 million, rounding out a trailing 12 month picture that shows total revenue of €3.5 billion and net income of €154.9 million. The company has seen quarterly revenue move from €906.8 million in Q4 2024 to €927.6 million in Q4 2025, while net income shifted from €8.9 million to €30.2 million over the same period. Over that timeframe,...
ENXTPA:VLTSA
ENXTPA:VLTSARenewable Energy

Voltalia (ENXTPA:VLTSA) Valuation Check After New Irish Solar EPC Contract Expands Project Pipeline

Voltalia (ENXTPA:VLTSA) is back in focus after its subsidiary Renvolt signed a turnkey EPC contract for ESB’s 124.2 megawatt Wexford Hub solar project in Ireland, expanding an already active partnership. See our latest analysis for Voltalia. Despite the new EPC win in Ireland and recent updates on its share capital and upcoming full year results, Voltalia’s €7.04 share price sits on a year to date share price return of 13.78% decline and a five year total shareholder return of 67.54% decline,...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

A Look At IDEAYA Biosciences (IDYA) Valuation After Reduced Net Losses In Recent Earnings

IDEAYA Biosciences (IDYA) shares are in focus after the company reported fourth quarter and full year 2025 results that showed smaller net losses and a lower loss per share versus the prior year. See our latest analysis for IDEAYA Biosciences. At a share price of US$30.76, IDEAYA’s recent 1 day share price return of 1.62% contrasts with a 30 day share price return of a 14.17% decline. The 1 year total shareholder return of 50.49% and 3 year total shareholder return of 76.78% indicate that,...
NYSE:NUVB
NYSE:NUVBPharmaceuticals

Assessing Nuvation Bio (NUVB) Valuation After Safusidenib Moves Into Phase 3 Astrocytoma Trial

Nuvation Bio (NUVB) is back in focus after the company finalized a protocol amendment for its global SIGMA study, moving safusidenib into a Phase 3 trial for high-risk IDH1-mutant astrocytoma. See our latest analysis for Nuvation Bio. The protocol amendment appears to have kept attention on Nuvation Bio, with a 1-day share price return of 1.91% and a 7-day share price return of 2.98% at a latest share price of $5.88. The year-to-date share price return of a 31.47% decline contrasts with a...
HLSE:ELISA
HLSE:ELISATelecom

Assessing Elisa Oyj (HLSE:ELISA) Valuation After Earnings Highlight Margin Resilience And AI-Driven Growth

Why Elisa Oyj (HLSE:ELISA) is back in focus Elisa Oyj (HLSE:ELISA) is drawing fresh attention after quarterly earnings that highlighted steady margins, continued automation and AI investments, and growing digital and international software services alongside its core telecom operations. See our latest analysis for Elisa Oyj. The 1 month share price return of 16.07% and 90 day share price return of 12.76% suggest momentum has picked up recently, even though the 3 year total shareholder return...